Mankind Pharma Ltd. IPO

The company is India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022. It is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Ltd. IPO Details

Check out the issue details for Mankind Pharma Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1080

Price Band

₹ 1026 - 1080

Issue Size

4326.36 Cr.

Issue Type

Book Built

Open

2023-04-25

Close

2023-04-27

Listingprice

₹ 1300

ListingGain

20.37%

Listing Date

2023-05-09

Company Financials

You can get the following financial statements of Mankind Pharma Ltd. as of now.

The details about the Mankind Pharma IPO is as:

  • The issue size of the IPO is 4326.36 Cr.
  • The price band for Mankind Pharma IPO is Rs 1026 to Rs 1080.
  • The shares of Mankind Pharma IPO will list on 9th May 2023.
  • The latest tentative GMP of Mankind Pharma IPO is Rs 97.
  • The shares of Mankind Pharma IPO is subscribed 15.32 Times as of 27th April 2023.

 

Mankind Pharma Ltd IPO Valuation

The approx valuation of Mankind Pharma Ltd IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 1080
Existing Shares (Qty) 40.05 Cr
EPS  Rs 35.78
PE Ratio 30.18x
Industry PE 40.16x

 

Mankind Pharma Ltd IPO Issue Size

Mankind Pharma Ltd IPO issue size is 4326.36 Cr.

Issue Amount
Fresh Issue 0 Cr
Offer For Sale 4326.36 Cr

 

Mankind Pharma Ltd IPO Market Lot

An Individual can apply for a minimum 1 lot of 13 shares and a maximum of 14 lots of 182 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 13 Rs 14,040
 Maximum 14 182 Rs 1,96,560

 

Mankind Pharma Ltd IPO Offer

The shares of Mankind Pharma IPO is subscribed 15.32 Times as of 27th April 2023. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 49.16 Times
Non-Institutional Minimum 15% 3.80 Times
Retail Individual Minimum 35% 0.92 Times
Total   15.32 Times

 

Mankind Pharma IPO Grey Market Premium

As on GMP (Tentative)
28 April 2023 Rs 30
1 May 2023 Rs 80
2 May 2023 Rs 90
3 May 2023 Rs 80
4 May 2023 Rs 80
5 May 2023 Rs 97

Mankind Pharma IPO GMP is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Find below the dates for Mankind Pharma Ltd IPO:

Schedule Date
Basis of Allotment 3 May 2023
Refunds 4 May 2023
Credit to Demat Account 5 May 2023
IPO Listing Date 9 May 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 5523.18 7486.22 8127.15 8629.25 9497.8
Total Expenditure 4151.05 5647.73 6429.29 6362.36 6934.73
Operating Profit 1372.13 1838.49 1697.86 2266.89 2563.07
Other Income 154.5 203.81 162.78 270.5 493.21
Interest 8.23 47.54 28.23 16.93 372.28
Depreciation 78.19 123.33 269.58 335.26 378.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 1440.21 1871.44 1562.84 2185.2 2305.99
Provision for Tax 355.83 482.01 314.58 412.57 421.74
Net Profit 1084.37 1389.42 1248.26 1876.16 1945.48
Adjusted EPS (Rs.) 2.71 3.47 3.12 4.42 4.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 40.06 40.06 40.06 40.06 41.26
Total Reserves 4694.21 6500.39 7743.85 9662.71 14599.01
Borrowings 0 0 0 0 4942.69
Other N/C liabilities 54.11 126.98 168.12 197.06 153.84
Current liabilities 1078.91 2271.27 1419.09 1616.56 4091.52
Total Liabilities 5867.29 8938.7 9371.12 11516.39 23828.32
Assets
Net Block 981.95 2921.3 3136.89 3546.28 3470.75
Capital WIP 165.51 355.28 437.83 134.74 191.36
Intangible WIP 0.06 31.28 56.95 74.7 16.07
Investments 1500.86 1657.08 2040.76 1975.85 15124.52
Loans & Advances 115.59 146.3 148.86 142.85 182.22
Other N/C Assets 16.04 14.45 36.1 15.12 150.09
Current Assets 3087.28 3813.01 3513.72 5626.85 4693.31
Total Assets 5867.29 8938.7 9371.12 11516.39 23828.32
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Other Income 84.96 94.83 105.76 69.82 219.32
Profit Before Tax 519.83 577.37 770.45 524.25 428.75
Tax 75.39 93.12 168.01 107.87 46.29
Profit After Tax 444.44 484.25 602.44 416.38 382.46
Adjusted EPS (Rs) 11.09 12.09 15.04 10.09 9.27

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 72.68 0
Mar 2025 72.7 0
Dec 2024 72.71 0
Sep 2024 74.87 0
Jun 2024 74.87 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 1440.21 1871.44 1562.84 2325.72 2390.36
Adjustment 96.74 -4.16 227 164.74 339.35
Changes in Assets & Liabilities -156.19 -585.61 294.21 -333.38 63.93
Tax Paid -397.38 -460.22 -285.06 -421 -471.48
Operating Cash Flow 983.38 821.44 1798.99 1736.08 2322.16
Investing Cash Flow -1127.16 -1360.27 -1040.61 -1665.19 -12178.83
Financing Cash Flow 88.87 578.63 -710.41 -4.73 9845.34
Net Cash Flow -54.91 39.81 47.96 66.16 -11.33
X